Stratipath Breast

JSON twin: https://www.healthaidb.com/software/stratipath-breast.json

Company Name

Stratipath

Product URL

https://www.stratipath.com/stratipath-breast-how-it-works/

Company URL

https://www.stratipath.com

Categories

• diagnostic Support
• clinical Care
• administrative Operations
• Diagnostic
• Clinical
• Administrative

Summary

Stratipath Breast is an AI-driven diagnostic tool that analyzes breast cancer tissue to assess the risk of disease progression, aiding clinicians in making informed treatment decisions.

Description

Stratipath Breast is an AI-based prognostic risk profiling solution for invasive early-stage breast cancer. It analyzes standard H&E-stained histopathology images to stratify tumors into low- and high-risk categories, providing rapid results within one hour. The tool is CE-IVD marked for clinical use in the EU and UK and has been validated in large-scale studies, demonstrating robust performance. It integrates seamlessly into existing diagnostic workflows and offers a cost-effective alternative to traditional molecular assays, enhancing precision medicine accessibility. Recent updates include support for core needle biopsies, expanding its application for earlier treatment planning. Stratipath Breast is currently implemented in several European hospitals and is available through partnerships with digital pathology platforms like Sectra and Roche's navify® Digital Pathology. The solution is offered as a Software as a Service (SaaS) model via subscription.

Api Available

unknown

Certifications

• CE-IVD marked for clinical use in the EU and UK

Company Founding

2019

Company Offices

• Sweden
• United Kingdom

Compliance

• CE-IVD marked for clinical use in the EU and UK

Customers

Data Residency

EU and UK data centers

Data Standards

• DICOM

Deployment Model

• SaaS

Features

• AI-based prognostic risk profiling for breast cancer
• Analysis of H&E-stained histopathology slides
• Stratification of invasive breast tumors into low- and high-risk groups
• Integration with digital pathology solutions
• Rapid result turnaround within one hour
• CE-IVD marked for clinical use in the EU and UK
• Clinical validation in large-scale studies
• Alternative to traditional molecular assays
• Software as a Service (SaaS) delivery model

Id

SW2573

Integration Partners

Integrations

• Sectra digital pathology solution
• Roche navify® Digital Pathology enterprise software
• Paige AppLab digital pathology platform

Languages Supported

• English
• Swedish

Last Updated

2025-10-11

License

commercial

Market Segment

• enterprise
• smb

Optional Modules

Os Platforms

• Web

Pricing Details

contact vendor

Pricing Model

subscription

Privacy Features

• Data anonymization
• Data minimization
• Compliance with GDPR

Product Code

SW2573

Product Name

Stratipath Breast

Ratings

Regions Available

• Sweden
• United Kingdom
• European Union

Related Urls

Release Year

Security Features

• Data encryption
• Role-based access control (RBAC)
• Audit logs
• Secure data transmission

Specialties

• Oncology
• Pathology
• Radiology

Support Channels

System Requirements

Target Users

• clinicians
• pathologists
• oncologists

Training Options

Type

product

User Reviews

Version

1.0

Alternatives

See related products

Canonical JSON

{
  "product_name": "Stratipath Breast",
  "company_name": "Stratipath",
  "product_url": "https://www.stratipath.com/stratipath-breast-how-it-works/",
  "company_url": "https://www.stratipath.com",
  "related_urls": [],
  "product_code": "SW2573",
  "summary": "Stratipath Breast is an AI-driven diagnostic tool that analyzes breast cancer tissue to assess the risk of disease progression, aiding clinicians in making informed treatment decisions.",
  "description": "Stratipath Breast is an AI-based prognostic risk profiling solution for invasive early-stage breast cancer. It analyzes standard H&E-stained histopathology images to stratify tumors into low- and high-risk categories, providing rapid results within one hour. The tool is CE-IVD marked for clinical use in the EU and UK and has been validated in large-scale studies, demonstrating robust performance. It integrates seamlessly into existing diagnostic workflows and offers a cost-effective alternative to traditional molecular assays, enhancing precision medicine accessibility. Recent updates include support for core needle biopsies, expanding its application for earlier treatment planning. Stratipath Breast is currently implemented in several European hospitals and is available through partnerships with digital pathology platforms like Sectra and Roche's navify® Digital Pathology. The solution is offered as a Software as a Service (SaaS) model via subscription.",
  "categories": [
    "diagnostic Support",
    "clinical Care",
    "administrative Operations",
    "Diagnostic",
    "Clinical",
    "Administrative"
  ],
  "market_segment": [
    "enterprise",
    "smb"
  ],
  "target_users": [
    "clinicians",
    "pathologists",
    "oncologists"
  ],
  "specialties": [
    "Oncology",
    "Pathology",
    "Radiology"
  ],
  "regions_available": [
    "Sweden",
    "United Kingdom",
    "European Union"
  ],
  "languages_supported": [
    "English",
    "Swedish"
  ],
  "pricing_model": "subscription",
  "pricing_details": "contact vendor",
  "license": "commercial",
  "company_offices": [
    "Sweden",
    "United Kingdom"
  ],
  "company_founding": "2019",
  "deployment_model": [
    "SaaS"
  ],
  "os_platforms": [
    "Web"
  ],
  "features": [
    "AI-based prognostic risk profiling for breast cancer",
    "Analysis of H&E-stained histopathology slides",
    "Stratification of invasive breast tumors into low- and high-risk groups",
    "Integration with digital pathology solutions",
    "Rapid result turnaround within one hour",
    "CE-IVD marked for clinical use in the EU and UK",
    "Clinical validation in large-scale studies",
    "Alternative to traditional molecular assays",
    "Software as a Service (SaaS) delivery model"
  ],
  "optional_modules": [],
  "integrations": [
    "Sectra digital pathology solution",
    "Roche navify® Digital Pathology enterprise software",
    "Paige AppLab digital pathology platform"
  ],
  "data_standards": [
    "DICOM"
  ],
  "api_available": "unknown",
  "system_requirements": "",
  "compliance": [
    "CE-IVD marked for clinical use in the EU and UK"
  ],
  "certifications": [
    "CE-IVD marked for clinical use in the EU and UK"
  ],
  "security_features": [
    "Data encryption",
    "Role-based access control (RBAC)",
    "Audit logs",
    "Secure data transmission"
  ],
  "privacy_features": [
    "Data anonymization",
    "Data minimization",
    "Compliance with GDPR"
  ],
  "data_residency": "EU and UK data centers",
  "customers": [],
  "user_reviews": [],
  "ratings": [],
  "support_channels": [],
  "training_options": [],
  "release_year": "",
  "integration_partners": [],
  "id": "SW2573",
  "slug": "stratipath-breast",
  "type": "product",
  "version": "1.0",
  "last_updated": "2025-10-11",
  "links_json": {
    "self": "https://www.healthaidb.com/software/stratipath-breast.json"
  }
}